Valeant Pharmaceuticals reported CAD653M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Amgen AMGN:US $ 1.31B 79M
Ani Pharmaceuticals ANIP:US $ 17.18M 1.64M
Aphria Inc APH:CN C$ 74.04M 19.84M
Aurora Cannabis Inc ACB:CN 48.61M 210K
Biogen BIIB:US $ 654.1M 16.8M
Bristol Myers Squibb BMY:US $ 1.79B 95M
Canopy Growth Corp WEED:CN C$ 141.71M 30.66M
Catalent CTLT:US $ 183M 1.1M
Corcept Therapeutics CORT:US $ 30.53M 504K
Danaher DHR:US $ 2.06B 96M
Eli Lilly And LLY:US $ 1.58B 107.8M
Endo International Ordinary Shares ENDP:US 241.92M 70.98M
Gilead Sciences GILD:US $ 1.18B 173M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Horizon Pharma HZNP:US 360.26M 5.06M
JAZZ PHA JAZZ:US 363.68M 65.35M
Lannett LCI:US $ 18.9M 2.67M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Pacira Pharmaceuticals PCRX:US $ 48.81M 2.01M
Perrigo Ordinary Shares PRGO:US 283.6M 11.7M
Phibro Animal Health PAHC:US $ 50.07M 604K
Prestige Brands PBH:US $ 72.98M 11.07M
Revance Therapeutics RVNC:US $ 51.12M 2.11M
Supernus Pharmaceuticals SUPN:US $ 72.03M 2.5M
Valeant Pharmaceuticals VRX:CN C$ 653M 32M
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
Zoetis ZTS:US $ 504M 9M